Marker Therapeutics, Inc. [MRKR] has reported $3.3 million in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $8.2 million.
Based in Houston, Texas, Marker Therapeutics, Inc. operates in the Manufacturing sector.